UnitedHealth Group (NYSE:UNH) Given New $440.00 Price Target at Truist Financial

UnitedHealth Group (NYSE:UNH) had its target price hoisted by equities research analysts at Truist Financial from $395.00 to $440.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Truist Financial’s price target indicates a potential upside of 15.05% from the stock’s previous close.

Several other equities research analysts have also issued reports on the stock. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research report on Tuesday, April 7th. Mizuho raised their price objective on UnitedHealth Group from $410.00 to $440.00 and gave the company an “outperform” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada raised their target price on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Robert W. Baird lifted their price objective on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $389.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $399.50.

UnitedHealth Group Trading Up 0.6%

NYSE:UNH traded up $2.13 during trading hours on Monday, reaching $382.44. 1,169,571 shares of the company were exchanged, compared to its average volume of 8,960,073. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The firm has a market cap of $347.31 billion, a price-to-earnings ratio of 28.87, a PEG ratio of 1.64 and a beta of 0.64. The stock has a 50 day simple moving average of $336.85 and a 200 day simple moving average of $321.55. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $404.15.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts predict that UnitedHealth Group will post 18.29 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.28% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $26,000. Anfield Capital Management LLC increased its holdings in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group during the 4th quarter valued at about $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.